Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants

Valeria Raparelli, Marco Proietti, Roberto Cangemi, Gregory Y H Lip, Deirdre A Lane, Stefania Basili

Research output: Contribution to journalReview articlepeer-review

155 Citations (Scopus)

Abstract

Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major adverse events and medication adherence is central to achieve good anticoagulation control. Non-vitamin K antagonist oral anticoagulants (NOACs) are as effective and safe as vitamin K antagonist (VKAs) in NVAF patients. Due to the absence of routine anticoagulation monitoring with NOACs treatment, concerns have been raised about patient's adherence to NOACs and real-life data demonstrates variability in adherence and persistence. A multi-level approach, including patients' preferences, factors determining physicians' prescribing habits and healthcare system infrastructure and support, is warranted to improve initiation and adherence of anticoagulants. Adherence to NOACs is paramount to achieve a clinical benefit. Implementation of educational programs and easy-to-use tools to identify patients most likely to be non-adherent to NOACs, are central issues in improving the quality of NVAF anticoagulation management.

Original languageEnglish
JournalThrombosis and Haemostasis
Volume117
Issue number2
Pages (from-to)209-218
Number of pages10
ISSN0340-6245
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants'. Together they form a unique fingerprint.

Cite this